Quadruple Agonist Reduced Weight Without Major Muscle Loss in Mid-Stage Trial

Summary
(MedPage Today) -- NATIONAL HARBOR, Md. -- An investigational oral quadruple receptor agonist led to substantial weight loss with preservation of lean mass, a randomized phase II trial presented here showed. By week 13, the two highest tested...
Description from Medpagetoday.
Who is covering this
-
Quadruple Agonist Reduced Weight Without Major Muscle Loss in Mid-Stage Trial
(MedPage Today) -- NATIONAL HARBOR, Md. -- An investigational oral quadruple receptor agonist led to substantial weight loss with preservation of lean mass, a randomized phase II trial presented here showed. By week 13, the two highest tested...
Comments
Comments need JavaScript.